Laurie E. Kilpatrick, PhD – leading researcher and educator at the Lewis Katz School of Medicine – has been named President of the Shock Society, a professional association of North American clinicians and researchers dedicated to improving the care of patients with trauma, shock, and sepsis.

Dr. Kilpatrick, a faculty member at the Katz School since 2009, is an expert on the lung and its response to life-threatening injury and disease. She holds professorships in multiple clinical and research departments at the Katz School and Temple Health, including the Department of Thoracic Medicine and Surgery and the Center for Inflammation and Lung Research.

Dr. Kilpatrick has been a member of the Shock Society for 30 years and has served the organization in several leadership capacities – including service as the Society's president-elect chair of its 42nd Annual Conference (2019).

The Shock Society focuses on research, education, and communication – all to improve patient outcomes," says Dr. Kilpatrick."We advance patient care for trauma, shock, and sepsis promoting essential research, hosting multidisciplinary educational forums, and working with the European, Indonesian and Japanese Shock societies to publish SHOCK®, the official journal of the International Federation of Shock Societies.

"An important mission of the Shock Society is to raise awareness of the enormous worldwide impact of trauma, shock, and sepsis on morbidity and mortality," says Dr. Kilpatrick, who is also a member of the SHOCK® journal's editorial board.

"At Temple, the top-notch training our students and residents receive in trauma, shock, and sepsis is aided by Dr. Kilpatrick's world-class research insights and her colleagues in the Shock Society community worldwide. I'm incredibly proud of her election to this important leadership post," says Amy J. Goldberg, MD, FACS, Interim Dean and leading trauma surgeon.

Dr. Kilpatrick's research at Temple focuses on vascular inflammation in sepsis and the regulation of leukocyte-endothelial interactions. She also investigates the role of immune cell phenotypes in disease pathology – and novel therapeutic approaches to modulate inflammation. She has a particular interest in acute lung injury and acute respiratory distress syndrome.

She is currently a member of the National Institutes of Health Surgery, Anesthesiology and Trauma (SAT) Study Section.

- Giselle Zayon